These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2268259)

  • 1. Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.
    Pfaffenbach GM; Melvold RW; Nathenson SG
    Biochem Genet; 1990 Aug; 28(7-8):433-41. PubMed ID: 2268259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. V. Effects of H-2Kb mutations on presentation of H-4 and H-3 alloantigens.
    Wettstein PJ
    J Immunol; 1982 Jun; 128(6):2629-33. PubMed ID: 6978909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular immunology of allograft rejection: insights from MHC mutants and crystal structure.
    DiSesa VJ
    J Heart Lung Transplant; 1991; 10(1 Pt 1):111-6. PubMed ID: 2007162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):31-41. PubMed ID: 6826208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications.
    Nathenson SG; Geliebter J; Pfaffenbach GM; Zeff RA
    Annu Rev Immunol; 1986; 4():471-502. PubMed ID: 3518748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological analysis of H-2 mutations using monoclonal antibodies.
    Bluestone JA; McKenzie IF; Melvold RW; Ozato K; Sandrin MS; Sharrow SO; Sachs DH
    J Immunogenet; 1984; 11(3-4):197-207. PubMed ID: 6084033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mutants to analyze regions on the H-2Kb molecule for interaction with immune receptors.
    Nathenson SG; Kesari K; Sheil JM; Ajitkumar P
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():521-8. PubMed ID: 2700943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL; Guimezanes A; Schmitt-Verhulst AM
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in H-2Kb influence the specificity of alloreactive effector cells included in the repertoire of H-2Db-restricted cytotoxic T lymphocytes against Moloney leukemia virus.
    Stukart MJ; Boes J; Melief CJ
    Immunogenetics; 1983; 17(4):427-36. PubMed ID: 6601058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
    Maziarz R; Allen H; Strominger JL; Flavell R; Biro PA; Burakoff SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6276-80. PubMed ID: 3875858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of H-2Kb mutant mice. I. Description and serological studies of B6.C-H-2bm9, -H-2bm10, and -H-2bm11.
    Morgan GM; McKenzie IF; Melvold RW
    Immunogenetics; 1980 Jul; 11(1):31-41. PubMed ID: 6160096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical studies of H-2K antigens from a group of related mutants. I. Identification of a shared mutation in B6-H-2bm5 and B6-H-2bm16.
    Yamaga KM; Pfaffenbach GM; Pease LR; McGovern D; Nisizawa T; Melvold RW; Kohn HI; Nathenson SG
    Immunogenetics; 1983; 17(1):19-29. PubMed ID: 6826207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H; Hämmerling G; Hengartner H
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histocompatibility gene mutation rates in the mouse: a 25-year review.
    Melvold RW; Wang K; Kohn HI
    Immunogenetics; 1997; 47(1):44-54. PubMed ID: 9382920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.
    Koeller D; Lieberman R; Miyazaki J; Appella E; Ozato K; Mann DW; Forman J
    J Exp Med; 1987 Sep; 166(3):744-60. PubMed ID: 2442290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.